News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
803,033 Results
Type
Article (61143)
Company Profile (455)
Press Release (741416)
Multimedia
Podcasts (169)
Webinars (26)
Section
Business (222793)
Career Advice (2976)
Deals (38458)
Drug Delivery (146)
Drug Development (88180)
Employer Resources (200)
FDA (17791)
Job Trends (16592)
News (378619)
Policy (36960)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2977)
Academic (2)
Accelerated approval (34)
Adcomms (36)
Allergies (154)
Alliances (54858)
ALS (183)
Alzheimer's disease (1797)
Antibody-drug conjugate (ADC) (351)
Approvals (17986)
Artificial intelligence (605)
Autoimmune disease (169)
Automation (40)
Bankruptcy (393)
Best Places to Work (12420)
BIOSECURE Act (22)
Biosimilars (205)
Biotechnology (265)
Bladder cancer (164)
Brain cancer (64)
Breast cancer (673)
Cancer (5098)
Cardiovascular disease (449)
Career advice (2524)
Career pathing (41)
CAR-T (311)
CDC (58)
Celiac Disease (2)
Cell therapy (824)
Cervical cancer (38)
Clinical research (74701)
Collaboration (1869)
Company closure (5)
Compensation (1192)
Complete response letters (74)
COVID-19 (2965)
CRISPR (100)
C-suite (913)
Cystic fibrosis (150)
Data (6389)
Decentralized trials (2)
Denatured (56)
Depression (149)
Diabetes (535)
Diagnostics (7182)
Digital health (51)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (282)
Drug pricing (226)
Drug shortages (35)
Duchenne muscular dystrophy (247)
Earnings (94892)
Editorial (67)
Employer branding (25)
Employer resources (171)
Events (129334)
Executive appointments (1047)
FDA (21021)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1575)
Gene editing (215)
Generative AI (55)
Gene therapy (673)
GLP-1 (1135)
Government (5272)
Grass and pollen (8)
Guidances (386)
Healthcare (20552)
HIV (64)
Huntington's disease (48)
IgA nephropathy (88)
Immunology and inflammation (297)
Immuno-oncology (65)
Indications (111)
Infectious disease (3261)
Inflammatory bowel disease (206)
Inflation Reduction Act (17)
Influenza (124)
Intellectual property (258)
Interviews (571)
IPO (17497)
IRA (61)
Job creations (4539)
Job search strategy (2067)
JPM (71)
Kidney cancer (18)
Labor market (93)
Layoffs (642)
Leadership (41)
Legal (9188)
Liver cancer (99)
Longevity (15)
Lung cancer (688)
Lymphoma (386)
Machine learning (44)
Management (65)
Manufacturing (856)
MASH (178)
Medical device (14746)
Medtech (14802)
Mergers & acquisitions (22051)
Metabolic disorders (1420)
Multiple sclerosis (170)
NASH (23)
Neurodegenerative disease (359)
Neuropsychiatric disorders (103)
Neuroscience (3131)
Neurotech (1)
NextGen: Class of 2026 (7324)
Non-profit (4998)
Now hiring (68)
Obesity (692)
Opinion (328)
Ovarian cancer (170)
Pain (218)
Pancreatic cancer (237)
Parkinson's disease (301)
Partnered (35)
Patents (520)
Patient recruitment (514)
Peanut (61)
People (65086)
Pharmaceutical (113)
Pharmacy benefit managers (33)
Phase 1 (23200)
Phase 2 (32664)
Phase 3 (24491)
Pipeline (5434)
Policy (339)
Postmarket research (3050)
Preclinical (10077)
Press Release (72)
Prostate cancer (253)
Psychedelics (58)
Radiopharmaceuticals (302)
Rare diseases (935)
Real estate (6897)
Recruiting (79)
Regulatory (27265)
Reports (66)
Research institute (2692)
Resumes & cover letters (467)
Rett syndrome (28)
RNA editing (18)
RSV (85)
Schizophrenia (161)
Series A (261)
Series B (203)
Service/supplier (19)
Sickle cell disease (104)
Special edition (26)
Spinal muscular atrophy (172)
Sponsored (45)
Startups (4099)
State (2)
Stomach cancer (20)
Supply chain (114)
Tariffs (100)
The Weekly (111)
Vaccines (1141)
Venture capital (100)
Weight loss (474)
Women's health (94)
Worklife (22)
Date
Today (153)
Last 7 days (644)
Last 30 days (2273)
Last 365 days (31904)
2026 (3657)
2025 (32207)
2024 (37384)
2023 (42300)
2022 (53530)
2021 (58279)
2020 (57108)
2019 (50504)
2018 (38343)
2017 (35485)
2016 (35734)
2015 (41774)
2014 (35919)
2013 (31368)
2012 (33416)
2011 (34027)
2010 (32691)
Location
Africa (1023)
Alabama (87)
Alaska (7)
Arizona (335)
Arkansas (14)
Asia (47290)
Australia (8217)
California (11647)
Canada (3359)
China (1192)
Colorado (494)
Connecticut (499)
Delaware (351)
Europe (104183)
Florida (1736)
Georgia (375)
Hawaii (4)
Idaho (65)
Illinois (941)
India (71)
Indiana (543)
Iowa (23)
Japan (446)
Kansas (131)
Kentucky (41)
Louisiana (29)
Maine (72)
Maryland (1439)
Massachusetts (8505)
Michigan (360)
Minnesota (667)
Mississippi (6)
Missouri (141)
Montana (36)
Nebraska (28)
Nevada (128)
New Hampshire (85)
New Jersey (3124)
New Mexico (32)
New York (3085)
North Carolina (1586)
North Dakota (10)
Northern California (5640)
Ohio (345)
Oklahoma (23)
Oregon (48)
Pennsylvania (2338)
Puerto Rico (25)
Rhode Island (49)
South America (1403)
South Carolina (68)
South Dakota (1)
Southern California (4528)
Tennessee (179)
Texas (1825)
United States (41814)
Utah (348)
Vermont (1)
Virginia (288)
Washington D.C. (88)
Washington State (966)
West Virginia (4)
Wisconsin (130)
Wyoming (2)
803,033 Results for "sonoma pharma formerly known as oculus innovative sciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2026 Financial Results
February 11, 2026
·
13 min read
Press Releases
Sonoma Pharmaceuticals Welcomes New Member of its Board of Directors and New Senior Vice President of Regulatory, Quality and Product Development
January 29, 2026
·
6 min read
Press Releases
Sonoma Pharmaceuticals to Exhibit at MEDICA 2025 in Düsseldorf
November 6, 2025
·
3 min read
Press Releases
National Rosacea Society Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced
November 14, 2025
·
3 min read
Press Releases
Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2026 Financial Results
November 5, 2025
·
13 min read
Press Releases
Sonoma Biotherapeutics Appoints Lisa Taylor Ash, JD, as Chief Legal Officer
August 26, 2025
·
2 min read
Insights
Five Trends That Got Everyone Talking in Pharma and Biotech This Year
In 2025, landmark obesity drug deals, China’s biotech surge, and AI’s deeper integration into pharma operations drove a year of transformation and renewed momentum for life sciences.
November 12, 2025
·
5 min read
·
Jennifer Smith-Parker
Press Releases
Sonoma Pharmaceuticals and Medline Industries Launch New HOCl Wound Cleanser for U.S. Hospitals
October 15, 2025
·
4 min read
Press Releases
Nuvectis Pharma, Inc. Reports 2025 Financial Results and Business Highlights
February 11, 2026
·
6 min read
Mergers & acquisitions
Five Assets Given Away by Big Pharma That Ultimately Got Bought for Billions
Drug candidates don’t usually move among Big Pharma, but these five biotechs helped facilitate such hand-offs, scooping up assets from one pharma on the cheap before being bought out for billions by another.
November 19, 2025
·
9 min read
·
Tristan Manalac
1 of 80,304
Next
